| Patent application number | Description | Published |
|---|
| 20100325354 | MECHANISM TO HANDLE EVENTS IN A MACHINE WITH ISOLATED EXECUTION - A platform and method for secure handling of events in an isolated environment. A processor executing in isolated execution “IsoX” mode may leak data when an event occurs as a result of the event being handled in a traditional manner based on the exception vector. By defining a class of events to be handled in IsoX mode, and switching between a normal memory map and an IsoX memory map dynamically in response to receipt of an event of the class, data security may be maintained in the face of such events. | 12-23-2010 |
| 20100325445 | MECHANISM TO HANDLE EVENTS IN A MACHINE WITH ISOLATED EXECUTION - A platform and method for secure handling of events in an isolated environment. A processor executing in isolated execution “IsoX” mode may leak data when an event occurs as a result of the event being handled in a traditional manner based on the exception vector. By defining a class of events to be handled in IsoX mode, and switching between a normal memory map and an IsoX memory map dynamically in response to receipt of an event of the class, data security may be maintained in the face of such events. | 12-23-2010 |
| 20100332760 | MECHANISM TO HANDLE EVENTS IN A MACHINE WITH ISOLATED EXECUTION - A platform and method for secure handling of events in an isolated environment. A processor executing in isolated execution “IsoX” mode may leak data when an event occurs as a result of the event being handled in a traditional manner based on the exception vector. By defining a class of events to be handled in IsoX mode, and switching between a normal memory map and an IsoX memory map dynamically in response to receipt of an event of the class, data security may be maintained in the face of such events. | 12-30-2010 |
| 20110087867 | PRIMITIVES TO ENHANCE THREAD-LEVEL SPECULATION - A processor may include an address monitor table and an atomic update table to support speculative threading. The processor may also include one or more registers to maintain state associated with execution of speculative threads. The processor may support one or more of the following primitives: an instruction to write to a register of the state, an instruction to trigger the committing of buffered memory updates, an instruction to read the a status register of the state, and/or an instruction to clear one of the state bits associated with trap/exception/interrupt handling. Other embodiments are also described and claimed. | 04-14-2011 |
| Patent application number | Description | Published |
|---|
| 20090036478 | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use - The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I | 02-05-2009 |
| 20090275602 | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use - The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I | 11-05-2009 |
| 20100222338 | BETA-SECRETASE MODULATORS AND METHODS OF USE - The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I | 09-02-2010 |
| 20110118250 | BETA-SECRETASE MODULATORS AND METHODS OF USE - The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I | 05-19-2011 |
